John V. Talley
Directeur Général chez Mitotherapeutix LLC
Profil
John V.
Talley is currently the Chief Executive Officer & Director at Mitotherapeutix LLC and also holds a Director position at IGF Oncology LLC.
He previously served as President, Chief Executive Officer & Director at Cactus Ventures, Inc. from 2012 to 2013 and at EpiCept Corp.
from 2011 to 2012.
He was also the Chief Executive Officer at Consensus Pharmaceuticals, Inc., Actinium Pharmaceuticals, Inc. and President & Chief Operating Officer at Penwest Pharmaceuticals Co. Additionally, he holds an undergraduate degree from the University of Connecticut.
Postes actifs de John V. Talley
| Sociétés | Poste | Début |
|---|---|---|
IGF Oncology LLC
 IGF Oncology LLC BiotechnologyHealth Technology IGF Oncology LLC develops novel cancer drugs. The company was founded by Hugh McTavish and is headquartered in Pine Springs, MN. | Directeur/Membre du Conseil | - |
Mitotherapeutix LLC
 Mitotherapeutix LLC BiotechnologyHealth Technology Mitotherapeutix LLC develops products for treatment of diseases by modifying or influencing metabolic pathways in the cell. The company is headquartered in Cheshire, CT. | Directeur Général | 01/07/2019 |
Anciens postes connus de John V. Talley
| Sociétés | Poste | Fin |
|---|---|---|
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | President | 18/04/2013 |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Cactus Ventures, Inc. operates as a blank check company. Cactus Ventures intends to locate and negotiate with a business entity for the merger of that target company into the company. The company was founded on October 6, 1997 and is headquartered in Carson City, NV. | President | 01/03/2013 |
| ACTINIUM PHARMACEUTICALS, INC. | Directeur Général | 28/02/2013 |
EpiCept Corp.
 EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | President | 20/08/2012 |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | President | - |
Formation de John V. Talley
| University of Connecticut | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Cactus Ventures, Inc. operates as a blank check company. Cactus Ventures intends to locate and negotiate with a business entity for the merger of that target company into the company. The company was founded on October 6, 1997 and is headquartered in Carson City, NV. | Finance |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Health Technology |
| Consensus Pharmaceuticals, Inc. | |
Mitotherapeutix LLC
Mitotherapeutix LLC BiotechnologyHealth Technology Mitotherapeutix LLC develops products for treatment of diseases by modifying or influencing metabolic pathways in the cell. The company is headquartered in Cheshire, CT. | Health Technology |
IGF Oncology LLC
IGF Oncology LLC BiotechnologyHealth Technology IGF Oncology LLC develops novel cancer drugs. The company was founded by Hugh McTavish and is headquartered in Pine Springs, MN. | Health Technology |
